Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

The Accord: Generic Event Marketability and Access Agreement is Open for Signature
Oct 31 2012
Washington, D.C. (October 31, 2012) – The Biotechnology Industry Organization (BIO) and the American Seed Trade Association (ASTA) announced today that...
Biotechnology Industry Organization Extends Agreement with VWR International, LLC
Oct 19 2012
Washington, D.C. (October 18, 2012) – The Biotechnology Industry Organization (BIO) has extended its agreement for over five years with VWR...
Registration and Housing for the 2013 BIO International Convention Now Available
Oct 18 2012
Washington, D.C. (October 18, 2012) – The Biotechnology Industry Organization (BIO) announces registration and housing for the 2013 BIO International...
BIO President Greenwood Issues Call to Arms to Renewable Energy Community
Oct 18 2012
Now is the time for a call to arms for the renewable energy industry to support and protect America’s Renewable Fuel Standard (RFS), Jim Greenwood,...
BIO Strongly Opposes RFS Waiver Requests in Comments to EPA
Oct 9 2012
Any waiver of the RFS would have little to no effect on corn prices, but would certainly harm biofuel producers and biotechnology companies across the United...
BIO Pacific Rim Summit to Showcase Role of Biomass in Building Biobased Economy
Oct 3 2012
Washington, D.C. (October 3, 2012) – The Biotechnology Industry Organization’s (BIO) 2012 Pacific Rim Summit on Industrial Biotechnology and...
BIO Announces Plenary Sessions for 11th Annual BIO Investor Forum
Oct 3 2012
Washington, D.C. (October 3, 2012) – The Biotechnology Industry Organization (BIO) announces plenary sessions for the BIO Investor Forum, an...
PDUFA V Sets New Course for Regulatory Science – Joint BIO/PhRMA Statement
Oct 1 2012
Washington, D.C. (October 1, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani andBiotechnology...
Renewable Fuel Stakeholders Launch National Campaign
Sep 26 2012
A large coalition of advanced and traditional renewable fuel stakeholders today joined forces to defend America’s Renewable Fuel Standard (RFS) and the...
BIO Praises Introduction of the High Technology Small Business Research Incentives Act
Sep 25 2012
Washington, D.C. (September 25, 2012) – The Biotechnology Industry Organization (BIO) applauds Sens. Robert Menendez (D-NJ) and Olympia Snowe (R-ME)...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...